Patents by Inventor Wing Shun CHEUNG

Wing Shun CHEUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazolopyridinone compounds
    Patent number: 11691970
    Abstract: Pyrazolopyridinone compounds, the pharmaceutical compositions comprising said compounds, and the use of said compounds as FGFR (fibroblast growth factor receptor) inhibitors and their use in the treatment of diseases, e.g. cancer.
    Type: Grant
    Filed: November 23, 2018
    Date of Patent: July 4, 2023
    Assignee: Janssen Pharmaceutica NV
    Inventors: Haibing Guo, Zhao-Kui Wan, Luoheng Qin, Qian Liu, Wing Shun Cheung
  • Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis B infections
    Patent number: 11639350
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject, and the compound has the structure of Formula I including any possible deuterated isomers, stereoisomers or tautomeric forms thereof.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: May 2, 2023
    Assignee: Janssen Pharmaceutica NV
    Inventors: Zhao-Kui Wan, Yimin Jiang, Xuedong Dai, Qian Liu, Wing Shun Cheung, Gang Deng, Liqiang Fu
  • DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES
    Publication number: 20220348571
    Abstract: The application describes dihydropyrimidine derivatives which are useful in the treatment or prevention of HBV infection or of HBV-induced diseases, more particularly of HBV chronic infection or of diseases induced by HBV chronic infection, as well as pharmaceutical or medical applications thereof.
    Type: Application
    Filed: June 25, 2019
    Publication date: November 3, 2022
    Inventors: Gang DENG, Yimin JIANG, Qian LIU, Chao LIANG, Zhao-Kui WAN, Wing Shun CHEUNG, Zhanling CHENG, Yanping XU
  • PYRAZOLOPYRIDINONE COMPOUNDS
    Publication number: 20220340598
    Abstract: The invention relates to new pyrazolopyridinone compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds as FGFR (fibroblast growth factor receptor) inhibitors and to their use in the treatment of diseases, e.g. cancer.
    Type: Application
    Filed: June 10, 2022
    Publication date: October 27, 2022
    Inventors: Haibing GUO, Zhao-Kui WAN, Luoheng QIN, Qian LIU, Wing Shun CHEUNG
  • Quinolinone compounds
    Patent number: 11384075
    Abstract: The invention relates to new quinolinone compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds as FGFR (fibroblast growth factor receptor) inhibitors and to their use in the treatment of diseases, e.g. cancer.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: July 12, 2022
    Assignee: Janssen Pharmaceutica NV
    Inventors: Haibing Guo, Zhao-Kui Wan, Luoheng Qin, Qian Liu, Wing Shun Cheung
  • Pyrazolopyridinone compounds
    Patent number: 11384099
    Abstract: Pyrazolopyridinone compounds, the pharmaceutical compositions comprising said compounds, and the use of said compounds as FGFR (fibroblast growth factor receptor) inhibitors and their use in the treatment of diseases, e.g. cancer.
    Type: Grant
    Filed: November 23, 2018
    Date of Patent: July 12, 2022
    Assignee: Janssen Pharmaceutica NV
    Inventors: Haibing Guo, Zhao-Kui Wan, Luoheng Qin, Qian Liu, Wing Shun Cheung
  • DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES
    Publication number: 20210220356
    Abstract: Provided herein are dihydropyrimidine derivatives which are useful in the treatment of HBV infection or HBV-induced diseases, as well as pharmaceutical or medical applications thereof.
    Type: Application
    Filed: May 7, 2019
    Publication date: July 22, 2021
    Inventors: Yimin JIANG, Zhao-Kui WAN, Wing Shun CHEUNG, Qian LIU, Gang DENG, Chao LIANG
  • Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseases
    Patent number: 11053235
    Abstract: The application describes dihydropyrimidine derivatives which are useful in the treatment or prevention of HBV infection or of HBV-induced diseases, more particularly of HBV chronic infection or of diseases induced by HBV chronic infection, as well as pharmaceutical or medical applications thereof.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: July 6, 2021
    Assignee: Janssen Sciences Ireland Unlimited Company
    Inventors: Gang Deng, Yimin Jiang, Qian Liu, Chao Liang, Zhao-Kui Wan, Wing Shun Cheung, Zhanling Cheng, Yanping Xu
  • PYRAZOLOPYRIDINONE COMPOUNDS
    Publication number: 20210147446
    Abstract: Pyrazolopyridinone compounds, the pharmaceutical compositions comprising said compounds, and the use of said compounds as FGFR (fibroblast growth factor receptor) inhibitors and their use in the treatment of diseases, e.g. cancer.
    Type: Application
    Filed: November 23, 2018
    Publication date: May 20, 2021
    Inventors: Haibing GUO, Zhao-Kui WAN, Luoheng QIN, Qian LIU, Wing Shun CHEUNG
  • PYRAZOLOPYRIDINONE COMPOUNDS
    Publication number: 20210147411
    Abstract: Pyrazolopyridinone compounds, the pharmaceutical compositions comprising said compounds, and the use of said compounds as FGFR (fibroblast growth factor receptor) inhibitors and their use in the treatment of diseases, e.g. cancer.
    Type: Application
    Filed: November 23, 2018
    Publication date: May 20, 2021
    Inventors: Haibing GUO, Zhao-Kui WAN, Luoheng QIN, Qian LIU, Wing Shun CHEUNG
  • New Quinolinone Compounds
    Publication number: 20210139470
    Abstract: The invention relates to new quinolinone compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds as FGFR (fibroblast growth factor receptor) inhibitors and to their use in the treatment of diseases, e.g. cancer.
    Type: Application
    Filed: June 26, 2018
    Publication date: May 13, 2021
    Inventors: Haibing GUO, Zhao-Kui WAN, Luoheng QIN, Qian LIU, Wing Shun CHEUNG
  • HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
    Publication number: 20200172532
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: June 26, 2018
    Publication date: June 4, 2020
    Inventors: Zhao-Kui WAN, Yimin JIANG, Xuedong DAI, Qian LIU, Wing Shun CHEUNG, Gang DENG, Liqiang FU
  • DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES
    Publication number: 20200048242
    Abstract: The application describes dihydropyrimidine derivatives which are useful in the treatment or prevention of HBV infection or of HBV-induced diseases, more particularly of HBV chronic infection or of diseases induced by HBV chronic infection, as well as pharmaceutical or medical applications thereof.
    Type: Application
    Filed: August 9, 2019
    Publication date: February 13, 2020
    Inventors: Gang DENG, Yimin JIANG, Qian LIU, Chao LIANG, Zhao-Kui WAN, Wing Shun CHEUNG, Zhanling CHENG, Yanping XU